PTCT PTC Therapeutics, Inc.
Healthcare$68.81-1.40%ClosedMarket Cap: $5.71B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$98.00
Target (Median)
$94.00
Target Range
$82.00 - $120.00
Upside from current price: 42.4%
Rating Distribution
4 Strong Buy6 Buy5 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | TD Cowen | upgrade | Buy | Hold |
| 2026-05-08 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2026-05-08 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-03-30 | Jefferies | downgrade | Hold | Buy |
| 2026-02-23 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-02-20 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2026-02-20 | B of A Securities | maintain | Buy | Buy |
| 2026-02-20 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-01-28 | Barclays | upgrade | Overweight | Equal Weight |
| 2025-12-01 | RBC Capital | downgrade | Sector Perform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $2.07 | $1.28B | 8 |
| Sun Dec 31 | $2.19 | $1.52B | 8 |
| Mon Dec 31 | $4.21 | $1.74B | 6 |
| Tue Dec 31 | $5.25 | $1.88B | 6 |